優越集團控股(01841.HK)年度收益約9780萬港元 同比減少約21.8%
格隆匯6月27日丨優越集團控股(01841.HK)公吿,截至2025年3月31日止年度,集團收益約9780萬港元,減少約21.8%。集團錄得除税後虧損約160萬港元,而截至2024年3月31日止年度則為除税後溢利約860萬港元。每股虧損0.40港仙。
隨着香港聯合交易所於2025年1月實施進一步無紙化上市改革,財經印刷行業正面臨重大挑戰。是次改革規定上市發行人須主要以電子方式與股東通訊,並取消就首次公開發售發出紙本申請表格的選項。儘管此轉變有助推動香港資本市場可持續實踐,但可能會令印刷文件的需求減少,潛在影響集團及財經印刷行業整體的盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.